Medical device and MedTech insights, news, tips and more
LifeSignals Wireless Medical Biosensor Receives FDA Clearance
July 21, 2020
LifeSignals Group, today announced USFDA 510(k) clearance has been received for their LifeSignals ECG Remote Monitoring Patch Platform. The LifeSignals ECG Remote Monitoring Patch Platform is a wireless remote monitoring system intended for use by healthcare professionals for the continuous collection of Electrocardiography (ECG) and Heart Rate monitoring in ambulatory, hospital, home and healthcare settings. Data is transmitted wirelessly from the LifeSignals Wireless Medical Biosensor LP1250 to a remote Secure Server for storage and analysis.
Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common Cardiac Arrhythmias such Atrial Fibrillation, enabling rapid treatment decisions, independent of patient location.
“This FDA clearance represents a major step forward in our drive to ‘untether’ patient monitoring systems,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable Biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding. Once in use, it enables remote patient monitoring services to be expanded rapidly and professionals can make faster treatment decisions while patients can be confident of receiving data-driven, personalized therapy.”
The LifeSignals Wireless Medical Biosensor LP1250 has several unique features:
- 72-hour data capture of two-channel ECG and Heart Rate data for enhanced patient diagnosis
- Single use device that reduces infection control concerns and operational costs
- Lightweight and splash-proof for improved patient comfort and compliance
- Proprietary patented single-chip LC1100 Life Signal Processor platform, allowing secure capture, storage and transmission of patient data even in ‘noisy’ multi-patient hospital environments
FDA clearance follows CE marking and HSA approval. The LifeSignals Wireless Medical Biosensor LP1250 will be sold worldwide as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
See Full Press Release at the Source: LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance
Press Release by: LifeSignals Group
Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.
Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.